Hollsteen
← Okta

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2016: −$158M · 10-K 0001660134-19-000006 filed Mar 14, 2019Equity incl. NCI · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2017: −$212M · 10-K 0001660134-19-000006 filed Mar 14, 2019Equity incl. NCI · Q1 FY2018: $166M · 10-Q 0001628280-17-006320 filed Jun 8, 2017Equity incl. NCI · Q2 FY2018: $153M · 10-Q 0001628280-17-009145 filed Sep 8, 2017Equity incl. NCI · Q3 FY2018: $156M · 10-Q 0001628280-17-012165 filed Dec 7, 2017Equity incl. NCI · Q4 FY2018: $199M · 10-K 0001660134-19-000006 filed Mar 14, 2019Equity incl. NCI · Q1 FY2019: $250M · 10-Q 0001660134-18-000013 filed Jun 8, 2018Equity incl. NCI · Q2 FY2019: $245M · 10-Q 0001660134-18-000020 filed Sep 7, 2018Equity incl. NCI · Q3 FY2019: $245M · 10-Q 0001660134-18-000023 filed Dec 6, 2018Equity incl. NCI · Q4 FY2019: $252M · 10-K 0001660134-19-000006 filed Mar 14, 2019Equity incl. NCI · Q1 FY2020: $239M · 10-Q 0001660134-19-000012 filed May 31, 2019Equity incl. NCI · Q2 FY2020: $251M · 10-Q 0001660134-19-000018 filed Aug 29, 2019Equity incl. NCI · Q3 FY2020: $398M · 10-Q 0001660134-19-000026 filed Dec 6, 2019Equity incl. NCI · Q4 FY2020: $405M · 10-K 0001660134-20-000006 filed Mar 6, 2020Equity incl. NCI · Q1 FY2021: $413M · 10-Q 0001660134-20-000012 filed May 29, 2020Equity incl. NCI · Q2 FY2021: $685M · 10-Q 0001660134-20-000019 filed Aug 28, 2020Equity incl. NCI · Q3 FY2021: $681M · 10-Q 0001660134-20-000026 filed Dec 3, 2020Equity incl. NCI · Q4 FY2021: $693M · 10-K 0001660134-23-000013 filed Mar 3, 2023Equity incl. NCI · Q1 FY2022: $683M · 10-Q 0001660134-21-000013 filed May 27, 2021Equity incl. NCI · Q2 FY2022: $6.0B · 10-Q 0001660134-21-000020 filed Sep 2, 2021Equity incl. NCI · Q3 FY2022: $6.0B · 10-Q 0001660134-21-000026 filed Dec 2, 2021Equity incl. NCI · Q4 FY2022: $5.9B · 10-K 0001660134-22-000010 filed Mar 7, 2022Equity incl. NCI · Q1 FY2023: $5.5B · 10-Q 0001660134-22-000026 filed Jun 3, 2022Equity incl. NCI · Q2 FY2023: $5.5B · 10-Q 0001660134-22-000042 filed Sep 1, 2022Equity incl. NCI · Q3 FY2023: $5.4B · 10-Q 0001660134-22-000056 filed Dec 1, 2022Equity incl. NCI · Q4 FY2023: $5.5B · 10-K 0001660134-23-000013 filed Mar 3, 2023Equity incl. NCI · Q1 FY2024: $5.5B · 10-Q 0001660134-23-000033 filed Jun 1, 2023Equity incl. NCI · Q2 FY2024: $5.6B · 10-Q 0001660134-23-000045 filed Aug 31, 2023Equity incl. NCI · Q3 FY2024: $5.7B · 10-Q 0001660134-23-000068 filed Dec 1, 2023Equity incl. NCI · Q4 FY2024: $5.9B · 10-K 0001660134-24-000025 filed Mar 1, 2024Equity incl. NCI · Q1 FY2025: $6.0B · 10-Q 0001660134-24-000088 filed May 30, 2024Equity incl. NCI · Q2 FY2025: $6.1B · 10-Q 0001660134-24-000138 filed Aug 29, 2024Equity incl. NCI · Q3 FY2025: $6.3B · 10-Q 0001660134-24-000168 filed Dec 4, 2024Equity incl. NCI · Q4 FY2025: $6.4B · 10-K 0001660134-25-000049 filed Mar 5, 2025Equity incl. NCI · Q1 FY2026: $6.6B · 10-Q 0001660134-25-000093 filed May 28, 2025Equity incl. NCI · Q2 FY2026: $6.8B · 10-Q 0001660134-25-000157 filed Aug 27, 2025Equity incl. NCI · Q3 FY2026: $6.9B · 10-Q 0001660134-25-000171 filed Dec 3, 2025Equity incl. NCI · Q4 FY2026: $7.0B · 10-K 0001660134-26-000020 filed Mar 5, 2026Equity incl. NCI · Q1 FY2027: $6.9B · 10-Q 0001660134-26-000051 filed May 29, 2026Equity incl. NCI · Q2 FY2027: $7.0B · 10-Q 0001660134-26-000069 filed Aug 27, 20265,4536,973−158Q1 FY2016Q2 FY2027Q2 FY2023
Q2 FY2023
5,453$M
All values (40)
PeriodValue ($M)Status
Q2 FY20276,973reported
Q1 FY20276,899reported
Q4 FY20266,999reported
Q3 FY20266,893reported
Q2 FY20266,754reported
Q1 FY20266,567reported
Q4 FY20256,405reported
Q3 FY20256,265reported
Q2 FY20256,133reported
Q1 FY20255,953reported
Q4 FY20245,888reported
Q3 FY20245,730reported
Q2 FY20245,640reported
Q1 FY20245,534reported
Q4 FY20235,466reported
Q3 FY20235,408reported
Q2 FY20235,453reported
Q1 FY20235,473reported
Q4 FY20225,922reported
Q3 FY20225,985reported
Q2 FY20226,042reported
Q1 FY2022683reported
Q4 FY2021693reported
Q3 FY2021681reported
Q2 FY2021685reported
Q1 FY2021413reported
Q4 FY2020405reported
Q3 FY2020398reported
Q2 FY2020251reported
Q1 FY2020239reported
Q4 FY2019252reported
Q3 FY2019245reported
Q2 FY2019245reported
Q1 FY2019250reported
Q4 FY2018199reported
Q3 FY2018156reported
Q2 FY2018153reported
Q1 FY2018166reported
Q4 FY2017−212reported
Q4 FY2016Noneerror

6 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: equity_total

More metrics for Okta
Sources & calculation
Value
$5.5B
Period
Q2 FY2023, ended Jul 31, 2022 · as of Jul 31, 2022 (balance as of date, not a sum)
Source
10-Q, filed Sep 1, 2022 · 0001660134-22-000042
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$5.5BSep 1, 202210-Q 0001660134-22-000042reported · confidence 1. · current